KRAS and neoplasm: Mutant KRAS (mKRAS) could also drive tumor-intrinsic granulocyte macrophage colony-stimulating factor (GM-CSF) and chemokine C-X-C motif ligand 1 (CXCL1) expression, promoting MDSC infiltration (Bayne et al., 2012).